Clinical Trial Update: Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166) [Phase 2]

View source ↗

Summary

Phase 2 trial update on pyrifazimine (TBI-166) assessing early bactericidal activity and safety in sensitive pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Sensitive Pulmonary Tuberculosis

Drugs mentioned

• Pyrifazimine (TBI-166)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Sensitive Pulmonary Tuberculosis | Phase 2 | Status: UNKNOWN